Epi-Minder is developing Minder®, a novel, epilepsy monitor to revolutionize the lives of millions of people suffering epilepsy and seizures. FDA breakthrough device designation is for devices that provide more…
The bridge financing round was oversubscribed with strong support from private investors, as well as existing shareholders including medical device leader CochlearThe UMPIRE clinical trial will expand to multiple clinical…
Epiminder is developing Minder®, an ultra-long term EEG implant to monitor brain activity to improve the standard of care for epilepsy sufferers.Seer Medical is developing revolutionary cloud and app-based platforms…
Epi-Minder Pty Ltd, a company developing the Minder™ ambulatory electroencephalography (EEG) monitoring device to transform clinical management of epilepsy and seizure-related conditions, is pleased to announce the appointment of Dr…
The Series A fund raising was strongly supported by private investors, as well as existing shareholders including medical device leader CochlearThe company is developing Minder™, a cloud-based, around-the-clock monitor that…